Omega-3 Fatty Acids to Improve Depression and Reduce Cardiovascular Risk Factors - No Study Results Posted - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Omega-3 Fatty Acids to Improve Depression and Reduce Cardiovascular Risk Factors

This study has been completed.

Study NCT00116857 Information provided by Washington University School of Medicine

First Received: June 30, 2005 Last Updated: November 8, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	November 2009
Primary Completion Date:	June 2009 (Final data collection date for primary outcome measure)

Publications:

Carney RM, Freedland KE, Rubin EH, Rich MW, Steinmeyer BC, Harris WS. Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial. JAMA. 2009 Oct 21;302(15):1651-7.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Bot M, Carney RM, Freedland KE, Rubin EH, Rich MW, Steinmeyer BC, Mann DL. Inflammation and treatment response to sertraline in patients with coronary heart disease and comorbid major depression. J Psychosom Res. 2011 Jul;71(1):13-7. Epub 2011 Jan 15.

Back to top of Main Content